*Mission*
Elsevier is committed to making genuine contributions to the science and
health communities.
Elsevier. Building Insights. Breaking Boundaries.

 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Elsevier websites
</wps/find/elsevierwebsites.cws_home/elsevierwebsites> | Alerts
</wps/find/home_content.cws_home/alertingservices>
	Elsevier 		

	Product information search 	
	Search all Elsevier sites 	
Search <javascript:submitSearchForm(document.forms['searchForm'])> 	
Advanced Product Search
</wps/find/advproductsearch.cws_home?action=product_search&search=no>

	

Go to Elsevier home page </wps/find/homepage.cws_home>

	
	Products
</wps/find/subject_area_browse.cws_home/?sh1State=-null-SAR-SAA-SAC-SAD-SAF-SA1-SAI-SAJ-SAK-SAQ-SAP-SAB-SAE-SAL-SAN-SAO-SAG-SAH-SAM&sh2State=&allParents=y&showAll=y>
	

	Biochemical and Biophysical Research Communications
</wps/find/journaldescription.cws_home/622790/authorinstructions?navopenmenu=-2>
	

	Journal information

	Product description
</wps/find/journaldescription.cws_home/622790/description#description> 	

	Editorial board
</wps/find/journaleditorialboard.cws_home/622790/editorialboard#editorialboard>
	

	Editorial Board Areas of Interest
<javascript:openWindow("/inca/publications/misc/622790areas.htm","yourchoice")>
	

	Audience </wps/find/journalaudience.cws_home/622790/description#audience> 	

	Abstracting/indexing
</wps/find/journalabstracting.cws_home/622790/abstracting#abstracting> 	

	Subscription information

	Bibliographic and ordering information
</wps/find/journalbibliographicinfo.cws_home/622790/description#bibliographicinfo>
	

	Conditions of sale
</wps/find/journalconditionsofsale.cws_home/622790/conditionsofsale#conditionsofsale>
	

	Dispatch dates
</wps/find/journaldispatchdates.cws_home/622790/dispatchdates#dispatchdates>
	

	Journal-related information

	Contact the publisher
</wps/find/journalcontactpublisher.cws_home/622790/contactpublisher#contactpublisher>
	

	Impact factor
</wps/find/journalimpactfactors.cws_home/622790/description#impactfactors> 	

	Most downloaded articles
<javascript:openWindow("http://top25.sciencedirect.com/?journal_id=0006291X","topdownload")>
	

	Other journals in same subject area
</wps/find/products_in_subject_and_group.cws_home/622790> 	

	Related publications
</wps/find/journalrelatedpublications.cws_home/622790/relatedpublications#relatedpublications>
	

	Support & contact </wps/find/supportfaq.cws_home/overview> 	

	About Elsevier </wps/find/intro.cws_home/ataglance> 	

	Select your view
</wps/find/journaldescription.cws_home/622790/authorinstructions?navopenmenu=4>
	

	

			
	
	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS	
		
	

*Guide for Authors*

/Biochemical and Biophysical Research Communications /(BBRC) is devoted
to the rapid dissemination of timely and significant observations in the
diverse fields of modern experimental biology. Articles submitted should
be written to emphasize clearly the novel aspects of the information
reported.

*Submission of Manuscripts*

It is a condition of publication that all manuscripts must be written in
clear and grammatical English and be submitted to the BBRC Web site at
External link http://ees.elsevier.com/bbrc. Authors are requested to
transmit the text and art of the manuscript in electronic form to this
address. No exceptions will be allowed; manuscripts submitted via any
other method will be returned. Each manuscript must also be accompanied
by a cover letter outlining the basic findings of the paper and its
significance. Complete instructions, including instructions for proper
artwork format, are available at the submission Web site. Authors who
have questions regarding the electronic submission process should
contact the Editorial Office prior to submission (e-mail:
bbrc@elsevier.com <mailto:bbrc@elsevier.com>; telephone: (619) 699-6359;
or fax: (619) 699-6859).

There are no submission fees or page charges.

*Peer Review Policy*

The practice of peer review is to ensure that good science is published.
It is an objective process at the heart of good scholarly publishing and
is carried out on all reputable scientific journals. Our Editorial Board
therefore plays a vital role in maintaining the high standards of BBRC
while ensuring that it retains the speed of publication necessary for a
rapid communication journal.

*Type of Peer Review*
BBRC is a rapid communications journal. As such, the decision to publish
an article rests entirely with the handling Editor. Manuscripts are
assigned to members of the Editorial Board based on expertise. This
Editor may accept the manuscript as it is, send it to a colleague for
review, or reject it. Requests for revisions are rare. Should the Editor
request revisions, the manuscript will be treated as a new submission.

*How long does the review process take?*
Authors of manuscripts can expect an accept or reject decision normally
within 2 weeks of receipt. Publication will then take place immediately
unless the author has, upon submission, requested an embargo.

*Manuscripts are accepted for review with the understanding that no
substantial portion of the study has been published or is under
consideration for publication elsewhere and that its submission for
publication has been approved by all of the authors and by the
institution where the work was carried out.* Redundant or duplicate
publication in another peer-reviewed primary research journal of the
same paper (or substantially similar paper) reporting the same results
arising from the same research work does not serve the research or
library community well, and any such publication will be subject to
review by the editor and to the retraction and removal policies of the
journal. Manuscripts that do not meet the general criteria or standards
for publication in BBRC will be immediately returned to the authors,
without detailed review.

Any manuscript rejected by one editor may not be resubmitted to a
different editor; any revised version should be sent to the original
editor. Note that all revisions will be processed as new submissions.

Upon acceptance of an article, authors will be asked to transfer
copyright (for more information on copyright, see External link
http://www.elsevier.com/copyright). This transfer will ensure the widest
possible dissemination of information. A letter will be sent to the
corresponding author confirming receipt of the manuscript. A form
facilitating transfer of copyright will be provided after acceptance.

If material from other copyrighted works is included, the author(s) must
obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by
authors in these cases: contact Elsevier Global Rights Department, P.O.
Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865
853333, e-mail: permissions@elsevier.com <mailto:permissions@elsevier.com>.

*Minireviews*

This section includes minireviews, commentaries, and views on relevant
subject matter, not simply short papers. Authors submitting a manuscript
for this section should, in a cover letter, indicate that they are
"submitting a manuscript for the Minireviews section." Minireviews
generally are invited; however, authors may inquire about potential
interest in a minireview. Manuscripts for the Minireviews section should
be indicated as for the attention of William J. Lennarz. Articles should
not exceed 9 to 10 double-spaced, typewritten pages (including tables,
figures, and references). One page of figures in articles in Minireviews
can be published in color, free of charge. The authors of minireviews
may, if they wish, include a limited number of annotated references. Two
hypothetical examples follow:

[1] J.Y. Smith, S.S. Doe, A novel retinoid-response gene set in vascular
smooth muscle cells, J. Biol. 280 (2000) 5-8. [A very concise review of
recent findings.]

[2] J.Y. Black, R.J. Blue, Magnetic field exposure induces DNA
degradation, Biol. Acta 120 (2001) 20-29. [The first study presenting
detailed information on the enzyme activity.]

*Preparation of Manuscript*

Manuscripts must be written in clear, concise, grammatical English.
Authors unfamiliar with English usage are encouraged to seek the help of
English-speaking colleagues in preparing their manuscripts or to use the
services described below.

/ *Language Editing:* /English language and copyediting services for
authors who want to publish in scientific, technical and medical
journals and need assistance before they submit their article or, before
it is accepted for publication should visit External link
http://www.elsevier.com/wps/find/authorshome.authors/languagepolishing.
For more information about language editing services, please contact
authorsupport@elsevier.com <mailto:authorsupport@elsevier.com> who will
be happy to deal with any questions. Please note Elsevier neither
endorses nor takes responsibility for any products, goods or services
offered by outside vendors through our services or in any advertising.
For more information please refer to our terms and conditions (External
link
http://www.elsevier.com/wps/find/termsconditions.cws_home/termsconditions).

/ *Manuscript length:* / Manuscripts should be double-spaced throughout,
with a minimum of 1-inch margins. The length of the article when
published will not exceed 6 printed journal pages, including all figures
and tables. To achieve this the submitted article length must be no
greater than 4,200 words (or 19,000 characters with spaces, whichever is
the greater) and 4 figures (n.b. any figure larger than half a page will
be counted as two figures). For information on article length for
Breakthroughs and Views, refer to the Minireview paragraph. Pages should
be numbered consecutively and organized as follows:

The /Title Page/ (p. 1) should contain an article title of less than 75
characters, the authors' names and complete affiliations, any footnotes
to the title, and the name and address for manuscript correspondence
(including e-mail address and fax numbers). *Note that the title should
not contain any jargon or nonstandard abbreviations.* The corresponding
author must confirm that the correspondence address in the manuscript
agrees with the address in the accompanying letter.

*Please ensure that all authors are properly listed and identified. No
additions or deletions to the author line will be permitted after the
initial submission of the paper. *

The /Abstract/ (p. 2) must be a single paragraph that summarizes the
main findings of the paper in fewer than 150 words. After the abstract a
list of up to 10 keywords that will be useful for indexing or searching
should be included.

The /Introduction/ should be as concise as possible, without subheadings.

/Materials and methods/ should be sufficiently detailed to enable the
experiments to be reproduced.

/Results/ and /Discussion/ may be combined and may be organized into
subheadings.

/Acknowledgments/ should be brief and should precede the references.

/References/ to the literature should be cited by numbers in square
brackets in the text and listed in numerical order with full article
titles included. Use the most recent edition of the Chemical Abstracts
Service Source Index for abbreviations of journal titles.

Reference to a journal publication: [1] A.G. Mueller, H.G. Joost, A.
Schurmann, Mouse ARF-related protein 1: genomic organization and
analysis of its promoter, Biochem. Biophys. Res. Commun. 292 (2002) 113-120.

Reference to a book: [2] W. Strunk Jr., E.B. White, The Elements of
Style, third ed., Macmillan, New York, 1979.

Reference to a chapter in an edited book: [3] O.R. Mettam, L.B. Adams,
How to prepare an electronic version of your article, in: E.S. Jones,
R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing
Inc., New York, 1999, pp. 281-304.

*Figures*

Number figures consecutively with Arabic numerals. Please visit our Web
site at External link http://www.elsevier.com/artworkinstructions for
detailed instructions on preparing electronic artwork.

*Color illustrations* should be sized close to the size expected in
publication. If, together with your accepted article, you submit usable
files of color figures, Elsevier will ensure, at *no additional charge,*
that these figures will appear in color on the Web (e.g., ScienceDirect
and other sites) regardless of whether these illustrations are
reproduced in color in the printed version. For color reproduction in
print, you will receive information regarding the costs from Elsevier
after receipt of your accepted article.

/Note:/ Because of technical complications that may arise in converting
color figures to gray scale, for the printed version should you not opt
for color in print, please submit in addition usable black-and-white
files corresponding to all the color illustration files.

*Tables*

Tables should be numbered consecutively with Arabic numerals in order of
appearance in the text. Type each table double-spaced on a separate page
with a short descriptive title typed directly above and with essential
footnotes below.

*Protein or Gene Databases*

The Editors encourage the use of databases as repositories for detailed
data on protein structure (e.g., X-ray crystallographic coordinates) and
on DNA sequences and mapping assignments. Verification of submission
and, when available, pertinent accession numbers should be provided with
the manuscripts. Authors wishing to enable other scientists to use the
accession numbers cited in their papers via links to these sources,
should type this information in the following manner:

For each and every accession number cited in an article, authors should
type the accession number in * _bold, underlined text_.* Letters in the
accession number should always be capitalized. (See example below.) This
combination of letters and format will enable the typesetter to
recognize the relevant texts as accession numbers and add the required
links to GenBank sequences.

Example: "GenBank accession nos. _ *AI631510* _, _ *AI631511* _, _
*AI632198* _, and _ *BF223228* _), a B-cell tumor from a chronic
lymphatic leukemia (GenBank accession no. _ *BE675048* _), and a T-cell
lymphoma (GenBank accession no. _ *AA361117* _)."

Authors are encouraged to check accession numbers used very carefully.
An error in a letter or number can result in a dead link. In the final
version of the printed article, the accession number text will not
appear bold or underlined. In the final version of the electronic copy,
the accession number text will be linked to the appropriate source in
the NCBI databases, enabling readers to go directly to that source from
the article.

*Chemical or Biological Hazards*

Chemical or biological hazards, if any, in carrying out the experiments
described should be clearly noted in the Materials and Methods section.
Any relevant safety precautions should be described. If an accepted code
of practice has been followed, a reference to the relevant standards
should be given.

*Ethics*

When conducting scientific research using human tissue and which is
intended for publication in BBRC, authors should follow procedures that
are in accordance with ethical standards as formulated in the Helsinki
Declaration of 1975 (revised 1983). When conducting experiments on
animals, authors should adhere to the local or national requirements for
the care and use of laboratory animals.

*Preparation of Supplementary Material*

Elsevier now accepts electronic supplementary material to support and
enhance your scientific research. Supplementary files offer additional
possibilities for publishing supporting applications, movies, animation
sequences, high-resolution images, background datasets, sound clips, and
more. Supplementary files supplied will be published online alongside
the electronic version of your article in Elsevier Web products,
including ScienceDirect (External link http://www.sciencedirect.com). To
ensure that your submitted material is directly usable, please provide
the data in one of our recommended file formats. Authors should submit
the material in electronic format together with the article and supply a
concise and descriptive caption for each file. Please note, however,
that supplementary material will not appear in the printed journal. For
more details, please see External link http://ees.elsevier.com/bbrc.

*Proofs*

Corresponding authors will receive proofs by e-mail (PDF proofs).
Because of the rapid publication schedule of BBRC, *authors must check
the proofs and return any corrections within 48 hours. * Corrections
should be restricted to typesetting errors, and all queries should be
answered. Please proofread the manuscript carefully before initial
submission.

*Distribution of Material*

Authors who publish a research article in BBRC must be prepared to
freely distribute to academic researchers for their own use any cell
lines, DNA clones, monoclonal antibodies, or genetically engineered mice
described in the article.

*Author Inquiries*

Visit External link http://www.elsevier.com/authors for the facility to
track accepted articles and set up e-mail alerts to inform you when an
article's status has changed. The Elsevier site also provides detailed
artwork guidelines, copyright information, frequently asked questions
and more. Contact details for questions arising after acceptance of an
article, especially those relating to proofs, are provided after
registration of an article for publication.

/March 2007 version/

	
		

		

		
	
Printer-friendly version <javascript:openPrinterFriendlyPage()>
  Printer-friendly version <javascript:openPrinterFriendlyPage()>

	

		

		
	
	
 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Privacy policy
</wps/find/privacypolicy.cws_home/privacypolicy> | Terms and Conditions
</wps/find/termsconditions.cws_home/termsconditions> | Feedback
</wps/find/feedbackform.cws_home> | A Reed Elsevier
<http://www.reed-elsevier.com> company 	
 Copyright © 2007 Elsevier B.V. </wps/find/homepage.cws_home> All rights
reserved.

	

